Renowned for its excellence in trial work, Kirkland & Ellis LLP has vast experience handling bet-the-company litigation for generic pharmaceutical and manufacturing companies involving complex technical and scientific issues. The practice serves as primary counsel on a wide range of product liability and mass tort matters, including multi-district litigations, class actions, defect/recall investigations, and appeals. Mike Brock is a seasoned litigator based in Washington DC specializing in representing pharma and life sciences companies in product liability and mass torts. In Chicago, trial lawyer Donna Welch spearheads the firm’s representation of Gilead in multiple matters regarding its Covid-19 antiviral drug Veklury – including product liability action related to alleged manufacturing negligence and class action regarding its marketing and promotion. The team saw significant expansion in January 2025 with the addition of Allison Brown, Jessica Davidson, Geoffrey Wyatt, Nina Rose, and Christopher Cox from Skadden, Arps, Slate, Meagher & Flom LLP. Kim Bueno joined the team in May 2025 from King & Spalding LLP.
L’éditorial du Legal 500
- Profil
- Réseaux sociaux
Clients clés
- AbbVie
- Allergan
- Crown Laboratories
- Eagle Pharmaceuticals
- Eli Lilly and Company
- Gilead Sciences
- GlaxoSmithKline
- Haleon
- Kenvue
- Ranbaxy Pharmaceuticals
Avocats
Hall of Fame
Avocats au sommet de leur profession, largement reconnus et respectés par l'ensemble du marché pour leur expertise éprouvée et leur intervention récurrente et longue date dans les dossiers les plus complexes et prestigieux.
Les grands avocats du marché
Avocats associés reconnus parmi les leaders du marché par leurs pairs et leurs clients, régulièrement présents dans les grands dossiers dans lesquels ils sont au premier plan.
Allison Brown
Kim Bueno
Autres avocats clés
Mike Brock; Donna Welch; Allison Brown; Jessica Davidson; Geoffrey Wyatt; Nina Rose; Christopher Cox